Skip to main content

Table 3 HRs of death, MI and IS/TIA associated with eGFR category

From: Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors

 

Death

MI

IS/TIA

HR a (95% CI)

HR a (95% CI)

HR a (95% CI)

eGFR calculated with the MDRD study equation, mL/min

15–29

2.79 (2.57–3.03)

2.34 (1.90–2.88)

1.78 (1.44–2.19)

30–59

1.38 (1.33-1.43)

1.37 (1.27-1.48)

1.13 (1.05-1.22)

  30–44

1.83 (1.74–1.92)

1.75 (1.56–1.97)

1.27 (1.13–1.43)

  45–59

1.25 (1.20–1.30)

1.27 (1.17–1.38)

1.09 (1.01–1.18)

≥60

1 (−)

1 (−)

1 (−)

eGFR calculated with the CKD-EPI equation, mL/min

15–29

2.79 (2.59–2.99)

2.21 (1.83–2.66)

1.73 (1.44–2.09)

30–59

1.41 (1.36-1.46)

1.38 (1.28-1.49)

1.20 (1.12-1.29)

  30–44

1.75 (1.67–1.84)

1.72 (1.54–1.92)

1.28 (1.15–1.43)

  45–59

1.29 (1.24–1.34)

1.27 (1.17–1.38)

1.19 (1.09–1.27)

≥60

1 (−)

1 (−)

1 (−)

  1. aAdjusted for sex, age at start date, duration of diabetes, BMI, smoking status, number of medications, HbA1c level, presence of hypertension hyperlidemia, and history of MI, IS/TIA and IHD.
  2. BMI, body mass index; CI, confidence interval; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HR, hazard ratio; IHD, ischemic heart disease; IS, ischemic stroke; MI, myocardial infarction; TIA, transient ischemic attack.